At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LH Labcorp Holdings Inc
Trading 09-17 12:56:13 EDT
323.77
-0.74
-0.23%
High326.48Low321.40Vol192.34K
Open326.48D1 Closing324.51Amplitude1.57%
Mkt Cap26.19BTradable Cap26.06BTotal Shares80.90M
T/O62.26MT/O Rate0.24%Tradable Shares80.50M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Centene Corp. Stock Underperforms Wednesday When Compared to Competitors
Dow Jones  ·  09-17 04:54
Centene Corp. Stock Underperforms Wednesday When Compared to Competitors
Pharma Sector Doubles Down on AI to Slash Costs, Timelines
Reuters  ·  09-16 21:53
Pharma Sector Doubles Down on AI to Slash Costs, Timelines
Labcorp Announces BRL 0.63 Per Unit Dividend, Payable Sept. 17
Reuters  ·  09-15 20:30
Labcorp Announces BRL 0.63 Per Unit Dividend, Payable Sept. 17
Labcorp Holdings Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains
Dow Jones  ·  09-15 05:02
Labcorp Holdings Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains
Evercore ISI Remains a Buy on Labcorp Holdings (LH)
TIPRANKS  ·  09-11
Evercore ISI Remains a Buy on Labcorp Holdings (LH)
UBS Adjusts Labcorp Price Target to $380 From $361, Maintains Buy Rating
MT Newswires Live  ·  09-11
UBS Adjusts Labcorp Price Target to $380 From $361, Maintains Buy Rating
Analysts Offer Insights on Healthcare Companies: Medicus Pharma Ltd (MDCX) and Labcorp Holdings (LH)
TIPRANKS  ·  09-11
Analysts Offer Insights on Healthcare Companies: Medicus Pharma Ltd (MDCX) and Labcorp Holdings (LH)
Labcorp price target raised to $380 from $361 at UBS
TIPRANKS  ·  09-11
Labcorp price target raised to $380 from $361 at UBS
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Labcorp Holdings (LH) and Edwards Lifesciences (EW)
TIPRANKS  ·  09-11
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Labcorp Holdings (LH) and Edwards Lifesciences (EW)
Labcorp price target raised to $330 from $320 at Barclays
TIPRANKS  ·  09-11
Labcorp price target raised to $330 from $320 at Barclays
U.S. Research Roundup- Adobe, Chewy, Mosaic
Reuters  ·  09-11
U.S. Research Roundup- Adobe, Chewy, Mosaic
Centene Corp. Stock Outperforms Competitors on Strong Trading Day
Dow Jones  ·  09-11
Centene Corp. Stock Outperforms Competitors on Strong Trading Day
Labcorp Backs Guidance, Forecasts Further Growth Ahead
Dow Jones  ·  09-10
Labcorp Backs Guidance, Forecasts Further Growth Ahead
Labcorp provides long-term outlook through 2029
TIPRANKS  ·  09-10
Labcorp provides long-term outlook through 2029
GUIDANCE: (LH) Labcorp Expects 2026 Adjusted EPS Range $18.10 to $18.55
MT Newswires Live  ·  09-10
GUIDANCE: (LH) Labcorp Expects 2026 Adjusted EPS Range $18.10 to $18.55
Labcorp Reaffirms 2026 Adjusted EPS Outlook of $18.10-$18.55
Reuters  ·  09-10
Labcorp Reaffirms 2026 Adjusted EPS Outlook of $18.10-$18.55
Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day
THOMSON REUTERS  ·  09-10
Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day
Labcorp - Expects 5%-8% Cagr Revenue and 8.5%-11.5% Cagr Adj EPS Through 2029
THOMSON REUTERS  ·  09-10
Labcorp - Expects 5%-8% Cagr Revenue and 8.5%-11.5% Cagr Adj EPS Through 2029
Labcorp - Reaffirms Full-Year 2026 Guidance
THOMSON REUTERS  ·  09-10
Labcorp - Reaffirms Full-Year 2026 Guidance
Labcorp Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors
Dow Jones  ·  09-10
Labcorp Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors

Introduction

Company Name.
Labcorp Holdings Inc
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Labcorp Holdings Inc. is a Delaware corporation founded in 1971 and a leading global life sciences company deeply integrated into patient care guidance. The company provides comprehensive clinical laboratory and end-to-end drug development services through its LabCorp Diagnostics (LCD) and Covance Drug Development (CDD) segments. Positioned at the convergence of research and care delivery, LabCorp combines world-class diagnostics and drug development capabilities to enable more precise and personalized healthcare.
Issue price:
--